News - Alliance for Clinical Trials in Oncology

Alliance Recognizes Wash U Medicine Cancer Study Professional with Clinical Research Integrity Award

November 9, 2026

Jennifer Frederick received Clinical Research Professional Research Integrity Service Excellence Award for dedication to helping cancer patients access clinical trials Wash U Medicine oncology clinical trial organizer Jennifer Frederick has received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award (CRP RISE) from the Alliance for Clinical Trials in Oncology. This award honors clinical…

News Releases

Lung Cancer Awareness Month: How Alliance Trials Advance Early Detection, Improve Treatments and Enhance Survivorship

November 6, 2026

Lung cancer remains the leading cause of cancer-related deaths in the United States, but advances in early detection and treatment are improving the outlook for patients. Over the past two decades, five-year survival rates have nearly doubled, rising from 15% to 27% – progress driven in large part by clinical research. This Lung Cancer Awareness…

Respiratory Cancer

News Releases

Alliance for Clinical Trials in Oncology Joins Movember Mission to Advance Men’s Cancer Awareness

November 2, 2026

NCI-supported cooperative group highlights its eight ongoing clinical trials focused on improving cancer detection, treatment, and survivorship Every November, millions worldwide grow mustaches and join Movember, a global movement launched in 2003 to spark conversations about men’s health, including prostate cancer, testicular cancer, and mental health. The initiative encourages men to challenge stigmas, prioritize their…

Cancer Control Genitourinary Cancer

Media Coverage

Sharing News from the Alliance: October Media Mentions

November 1, 2026

The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, and investigator achievements, we are showcasing the real-world progress you help make possible. See where the Alliance was mentioned in October 2026…

Breast Cancer Cancer Control Gastrointestinal Cancer

Features

Three-Week Radiation Course a Safe Option for Breast Cancer Patients Undergoing Reconstruction, Alliance Trial Shows

October 28, 2026

Published in Journal of Clinical Oncology, findings provide evidence that shortening radiation schedule does not sacrifice treatment success or impair reconstruction efforts Results of a national clinical trial led by the Alliance for Clinical Trials in Oncology in conjunction with NRG Oncology and the Canadian Cancer Trials Group show that a shorter, three-week radiation schedule…

Cancer Control

News Releases

Breast Cancer Awareness Month: Advancing Breast Cancer Research through Clinical Trials

October 16, 2026

Research progress in breast cancer is saving lives, improving treatments, and offering hope to millions of people. Yet breast cancer remains a significant public health challenge, underscoring the continued need for research, earlier detection, and more effective treatment options. Breast cancer is the most common cancer in American women, after skin cancers, accounting for about…

Breast Cancer Cancer Control

Features

Alliance Announces FDA Approval of Atezolizumab Based on Results from the Phase III ATOMIC Trial for Patients with Stage III dMMR Colon Cancer

October 9, 2026

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq®) in combination with fluoropyrimidine and oxaliplatin chemotherapy, for the adjuvant treatment of patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR). The approval is based on…

Gastrointestinal Cancer

Features

Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE

October 5, 2026

A Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with SignateraTM MRD-Guided CDK4/6 Inhibitor Therapy in ER-Positive/HER2-Negative Early-Stage Breast Cancer Trial will utilize Natera’s ultrasensitive MRD test, Signatera Genome with Phased and Structural Variants, paired with giredestrant monotherapy, Genentech’s oral SERD, with the objective to spare patients from unnecessary CDK4/6…

Breast Cancer

Media Coverage

Sharing News from the Alliance: September Media Mentions

October 4, 2026

The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. See where the Alliance was mentioned September 2026 in…

Breast Cancer Gastrointestinal Cancer Genitourinary Cancer Leukemia Neuro-Oncology

Features

Alliance Trial Finds Fractionated Radiosurgery Reduces Cancer Recurrence After Surgery for Large Brain Metastases

September 28, 2026

Presented at ASTRO plenary session, Phase III trial results show three to five radiation treatments improved control at the surgical site compared with a single treatment Delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced the risk of cancer returning at the surgical site compared with delivering…

Neuro-Oncology

All News

Categories

Alliance Committee

Browse by Year